Oncology Venture provides news on its clinical development projects dovitinib, 2X‑121 and LiPlaCis

NEXT STORY
Global Point of Care Diagnostics/Testing Market 2019-2025 – Growing Demand for Home Healthcare and the Introduction of Advance Technology Enabled Products
PREV STORY
Sandoz enters agreement for proposed trastuzumab biosimilar, currently in Phase III development, to treat selected HER2-positive cancer tumors
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

BW Health Group Introduces Kander™ Patient Feedback System

author_avatar
NASDAQ Market News

Innate Pharma to participate in the 10th Annual SVB Leerink Global Healthcare Conference

author_avatar
NASDAQ Market News

RedHill Biopharma Announces Full Results from Positive MAP US Phase 3 Study and Supportive Top-Line Results from MAP US2 Open-Label Extension Study with RHB-104 in Crohn’s Disease

author_avatar
NASDAQ Market News